Glucocorticoid regulation of corticotropin-releasing factor1 receptor expression in pituitary-derived AtT-20 cells

Molecular Pharmacology

Volumn 51, Issue 5, 1997, Pages 794-799

  Iredale, Philip A ^a   Duman, Ronald S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RECEPTOR; CYCLOHEXIMIDE; DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA; PROOPIOMELANOCORTIN; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONE RECEPTOR INTERACTION; HYPOPHYSIS CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0030985212     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.5.794     Document Type: Article

References (40)

1. Haynes, R. C. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones, in The Pharmacological Basis of Therapeutics (A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor, eds.). Pergamon Press, New York, 1431-1462 (1990).
2. Meyer, J. S. Biochemical effects of corticosteroids on neural tissues. Physiol. Rev. 65:947-1020 (1985).
3. Dallman, M. F., S. F. Akana, C. S. Cascio, D. N. Darlington, L. Jacobson, and N. Levin. Regulation of ACTH secretion: variations on a theme of B. Rec. Prog. Horm. Res. 43:113-173 (1987).
4. Jones, M. T., and B. Gillham. Factors involved in the regulation of adrenocorticotropic hormone/β-lipotropic hormone. Physiol. Rev. 68:743-818 (1988).
5. Wynn, P. C., R. L. Hauger, M. C. Holmes, M. A. Millan, K. J. Catt, and G. Aguilera. Brain and pituitary receptors for corticotropin releasing factor: localization and differential regulation after adrenalectomy. Peptides 5:1077-1084 (1984).
6. Young, E. A., R. F. Haskett, V. Murphy-Weinberg, S. J. Watson, and H. Akil. Loss of glucocorticoid fast feedback in depression. Arch. Gen. Psychiatry 48:693-699 (1991).
7. Gold, P. W., F. K. Goodwin, and G. P. Chrousos. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2). N. Engl. J. Med. 319:413-420 (1988).
8. King, M. S., and A. J. Baertschi. The role of intracellular messengers in adrenocorticotropin secretion in vitro. Experientia 46:26-40 (1990).
9. Clark, A. J., M. F. Stewart, P. M. Lavender, W. Farrell, S. R. Crosby, L. H. Rees, and A. White. Defective glucocorticoid regulation of proopiomelanocortin gene expression and peptide secretion in a small cell lung cancer cell line. J. Clin. Endocrinol. Metab. 70:485-490 (1990).
10. Familari, M., and J. W. Funder. Isolated pituitary cells: glucocorticoids do not rapidly suppress ACTH secretion in response to CRF. Am. J. Physiol. 256:E145-E151 (1989).
11. Antoni, F. A., and G. Dayanithi. Evidence for distinct glucocorticoid and guanine 3′,5′-monophosphate-effected inhibition of stimulated adrenocorticotropin release in vitro. Endocrinology 126:1355-1360 (1990).
12. Childs, G. V., J. L. Morell, A. Niendorf, and G. Aguilera. Cytochemical studies of corticotropin-releasing factor (CRF) receptors in anterior lobe corticotropes: binding, glucocorticoid regulation, and endocytosis. Endocrinology 119:2129-2142 (1986).
13. Pozzoli, G., L. M. Bilezikjian, M. H. Perrin, A. L. Blount, and W. W. Vale. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology 137:65-71 (1996).
14. Suda, T., F. Tozawa, M. Yamada, T. Ushiyama, N. Tomori, T. Sumitomo, Y. Nakagami, and K. Shizume. In vitro study on proopiomelanocortin messenger RNA levels in cultured rat anterior pituitary cells. Life Sci. 42:1147-1152 (1988).
15. Gagner, J. P., and J. Drouin. Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH. Mol. Cell. Endocrinol. 40:25-32 (1985).
16. Vig, E., T. J. Barrett, and W. V. Vedeckis. Coordinate regulation of glucocorticoid receptor and c-jun mRNA levels: evidence for cross-talk between two signaling pathways at the transcriptional level. Mol. Endocrinol. 8:1336-1346 (1994).
17. Gagner, J. P., and J. Drouin. Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3′,5′-cyclic adenosine monophosphate, and glucocorticoids. Mol. Endocrinol. 1:677-382 (1987).
18. Drouin, J., M. A. Trifiro, R. K. Plante, M. Nemer, P. Eriksson, and O. Wrange. Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Mol. Cell. Biol. 9:5305-5314 (1989).
19. Wynn, P. C., J. P. Harwood, K. J. Catt, and G. Aguilera. Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses. Endocrinology 116:1653-1659 (1985).
20. Battaglia, G., E. L. Webster, and E. B. De Souza. Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system. Synapse 1:572-581 (1987).
21. Sakai, K., N. Horiba, Y. Sakai, F. Tozawa, H. Demura, and T. Suda. Regulation of corticotropin-releasing factor receptor messenger ribonucleic acid in rat anterior pituitary. Endocrinology 137:1758-1763 (1996).
22. 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex. J. Neurochem. 60:1335-1343 (1993).
23. Hosoda, K., L. R. Fitzgerald, V. A. Vaidya, G. K. Feussner, P. H. Fishman, and R. S. Duman. Regulation of β2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition. Mol. Pharmacol. 48:206-211 (1995).
24. Kiely, J., J. R. Hadcock, S. W. Bahouth, and C. C. Malbon. Glucocorticoids down-regulate β1-adrenergic-receptor expression by suppressing transcription of the receptor gene. Biochem. J. 302:397-403 (1994).
25. Greenberg, M. E., and Bender, T. P. Identification of newly transcribed RNA, in Current Protocols in Molecular Biology (F. M. Ausbel, R. Bent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds.). John Wiley and Sons, New York, 4.10.1-4.10.9 (1990).
26. 1 receptor expression by stress and agonist treatments in brain and cultured cells. Mol. Pharmacol. 50:1103-1110 (1996).
27. Gerwins, P., and B. B. Fredholm. Glucocorticoid receptor activation leads to up-regulation of adenosine A1 receptors and down-regulation of adenosine A2 responses in DDT1 MF-2 smooth muscle cells. Mol. Pharmacol. 40:149-155 (1991).
28. Collins, S., M. G. Caron, and R. J. Lefkowitz. β-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J. Biol. Chem. 263:9067-9070 (1988).
29. Douglas, J. G. Corticosteroids decrease glomerular angiotensin receptors. Am. J. Physiol. 252:F453-F457 (1987).
30. Yang-Yen, H. F., J. C. Chambard, Y. L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and M. Karin. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215 (1990).
31. Schule, R., P. Rangarajan, P. Kliewer, L. J. Ransone, J. Bolado, N. Yang, I. M. Verma, and R. M. Evans. Functional antagonism between oncoprotein c-Jun and steroid hormone receptors. Cell 62:1217-1226 (1990).
32. Angel, P., and M. Karin. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:129-157 (1991).
33. Lee, N. H., J. Earle-Hughes, and C. M. Fraser. Agonist-mediated destabilization of m1 muscarinic acetylcholine receptor mRNA. Elements involved in mRNA stability are localized in the 3′-untranslated region. J. Biol. Chem. 269:4291-4298 (1994).
34. 1B-adrenergic receptor mRNA in vascular smooth muscle cells. J. Biol. Chem. 269:1705-1710 (1994).
35. Hadcock, J. R., H. Y. Wang, and C. C. Malbon. Agonist-induced destabilization of β-adrenergic receptor mRNA. J. Biol. Chem. 264:19928-19933 (1989).
36. Iannuzzi, D. M., R. Ertsey, and P. L. Ballard. Biphasic glucocorticoid regulation of pulmonary SP-A: characterization of inhibitory process. Am. J. Physiol. 264:L236-L244 (1993).
37. Port, J. D., L. Y. Huang, and C. C. Malbon. β-adrenergic agonists that down-regulate receptor mRNA up-regulate a Mr 35,000 protein(s) that selectively bind to β-adrenergic receptor mRNAs. J. Biol. Chem. 267: 24103-24108 (1992).
38. r) 35,000 β-adrenergic receptor mRNA-binding protein binds transcripts of G-protein-linked receptors which undergo agonist-induced destabilization. J. Biol. Chem. 270:12787-12793 (1995).
39. Rosewicz, S., A. R. McDonald, B. A. Maddux, I. D. Goldfine, R. L. Miesfeld, and C. D. Logsdon. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J. Biol. Chem. 263:2581-2584 (1988).
40. Burnstein, K. L., D. L. Bellingham, C. M. Jewell, F. E. Powell-Oliver, and J. A. Cidlowski. Autoregulation of glucocorticoid receptor gene expression. Steroids 56:52-58 (1991).